Page 1

Life MD * Source : LifeMD , Inc. August 12 , 2021 16:05 ET LifeMD Reports Q2 2021 Revenue Up 145 % to Record $ 22.3 Million , Driven by Reduced Acquisition Costs and Strong Retention • New patient Customer Acquisition Cost ( CAC ) decreased 8 % sequentially , while new patient acquisitions per day for comparable brands increased 11 % • Revenue increased to a record $ 22.3 million , up 145 % from the same year - ago period • 93 % of Q2 2021 revenue generated by subscriptions , up from 56 % in the same year - ago period • Platform Contribution of $ 16.5 million , 74 % of net revenue , up 145 % from the same year - ago period • Total telehealth order volume grew 155 % to 199,764 NEW YORK , Aug. 12 , 2021 ( GLOBE NEWSWIRE ) -- LifeMD , Inc. ( NASDAQ : LFMD ) , a leading direct - to - patient telehealth company , reported results for the second quarter ended June 30 , 2021. All figure comparisons are to the same year - ago quarter unless otherwise noted . Management will host a conference call today at 4:30 p.m. Eastern time to discuss the results . Q2 Financial Highlights • Record revenue of $ 22.3 million , up 145 % • 93 % of revenue generated by subscriptions , up from 56 % • Gross profit totaled $ 18.1 million , or 81 % of net revenues , up 145 % • Platform Contribution of $ 16.5 million , up 145 % ( see definition of this non - GAAP financial measure and reconciliation to GAAP , below ) • $ 17.4 million in cash as of June 30 , 2021 , versus $ 9.2 million as of December 31 , 2020 Q2 Operational Highlights • Strong new patient acquisition followed the launch of Nava MDTM in the prior quarter , with favorable Nava MD unit economics showing support for a two- to four - month payback on CAC • Drove an approximate 30 % efficiency improvement in media spend resulting in Customer Acquisition • Costs ( CAC ) that decreased 8 % sequentially despite media rates in our core advertising channels rising by more than 20 % . Daily rate of new patient acquisitions increased by 11 % sequentially with improved cost efficiency • Total patients and customers served nationwide surpassed 360,000 during the quarter • Telemedicine orders increased 155 % to approximately 200,000 • Appointed veteran pharmaceutical strategy and corporate development executive , Alexander Mironov , as president of LifeMD . The appointment reflects LifeMD's focus on broadening its direct - to - patient pharmaceutical capabilities and further diversifying its telehealth portfolio with patented products . • Made significant investments in technology and personnel to support the launch of our LifeMD branded primary care offering later this quarter . Subsequent Events • LifeMD launched transformational partnerships with a leading provider of laboratory diagnostic services and Axle Health , a leading national provider of in - home diagnostic services , to provide patients with preferred pricing on more than 150 of the most common laboratory diagnostic tests and a national network of more than 2,200 labs . • Teamed with Particle Health , a leading provider of HIPAA - compliant electronic medical records , to enable LifeMD care providers to have a deeper understanding of their patients ' medical histories in a real - time , user - friendly HIPAA compliant format . ( $ in 000s ) Three Months Ended June 30 Y - o - Y